|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Palliative treatment of esophageal tumors显示文摘 | Assisi D Grassi A | 2002 | Jexp Clin Cancer Res2002，21，5： | 1 |
| 2 | Endoscopic treatment of neoplastic enteral obstruction by means of self-expanding metal stents显示文摘 | Belverde B Lapenta R Assisi D | 2013 | Ann Ital Chit2013，84，2： | 1 |
| 3 | Palliative treatment of esophageal tumors 显示文摘 | Lapenta R Assisi D Grassi A | 2002 | Jexp Clin Cancer Res2002，21，5： | 1 |
| 4 | D-Aspartic acid and nitric oxide as regulators of androgen production in boar testis 显示文摘 | Lamanna C Assisi L Vittoria A | 2007 | Theriogenology2007，67，2： | 1 |
| 5 | Polyunsaturated fatty acids and anthropometric indices of children in rural China 显示文摘 | Assisi A Banzi R Buonocore C | 2006 | Eur J Clin Nutr2006，60，9： | 1 |
| 6 | Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients 显示文摘 | Stigliano V Assisi D Cosimelli M | 2008 | J Exp Clin Cancer Res2008，27，： | 1 |
| 7 | Current trends in screening and secondary prevention of colorectal cancer显示文摘 | Crespi M Stigliano V Assisi D | 2001 | Hepatogastroenterology2001，48，42： | 1 |
| 8 | Occurrence of Sex Steroid Hormones and Their Binding Proteins in Octopus vulgaris Lam显示文摘 | Antimo D’aniello Anna Di Cosmo Carlo Di Cristo Loredana Assisi Virgilio Botte M.Maddalena Di Fiore | 1996 | Biochemical and Biophysical Research Communications1996，，3： | 1 |
| 9 | Palliative treatment of esophageal tumors显示文摘 | Lapenta R Assisi D Grassi A | 2002 | J Exp Clin Cancer Res2002，21，： | 1 |
| 10 | D-Aspartic acid and nitric oxide as regulators of androgen production in boar testis 显示文摘 | Lamanna C Assisi L Vittoria A | 2007 | Theriogenology2007，67，2： | 1 |
| 11 | Current trentds in screening and secondary prevention of colorectal cancer显示文摘 | Brenner H Amdt V Assisi D | 2001 | Br J Can-cer2001，48，42： | 1 |
| 12 | Elective neck irradiation in squamous carcinoma of the head neck显示文摘 | Mendenhall WM Million RR Assisi JH | 1980 | Head Neck Surg1980，3，1： | 1 |
| 13 | Current trents in screening and secondary prevention of colorectal cancer显示文摘 | BRENNER H ARNDT V ASSISI D | 2001 | Br J Cancer2001，48，42： | 1 |
| 14 | C-Myb, serum P-53M, genetic instability, labeling index and endoscopic findings in patients with adenoma or colorectal cancer显示文摘 | Assisi D Grassi A La Penta R | 2004 | J Exp Clin Cancer Res2004，23，3： | 1 |
| 15 | Current trentds in screening and secondary prevention of eoloreetal cancer 显示文摘 | Crespi M Stigliano V Assisi D | 2001 | Hepatogastroenterology2001，48，42： | 1 |
| 16 | Palliative treatment of esophageal tumors显示文摘 | Lapenta R Assisi D Grassi A | 2002 | J Exp Clin Cancer Res2002，21，5： | 1 |
| 17 | Palliative treatment of esopha g eal tumors显示文摘 | Assisi D Grassi A | 2002 | J Exp Clin Cancer Res2002，21，5： | 1 |
| 18 | Current trents in screening and secondary prevention of colorectal cancer 显示文摘 | BRENNER H ARNDT V ASSISI D | 2001 | Br J Cancer2001，48，42： | 1 |
| 19 | Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review显示文摘BACKGROUND Self-expandable metal stents(SEMSs) are frequently used in the setting of palliation for occluding, inoperable colorectal cancer(CRC). Among possible complications of SEMS positioning, re-obstruction is the most frequent. Its management is controversial, potentially involving secondary stent-in-stent placement, which has been poorly investigated. Moreover, the issue of secondary stent-in-stent re-obstruction and of more-than-two colonic stenting has never been assessed. We describe a case of tertiary SEMS-in-SEMS placement, and also discuss our practice based on available literature.CASE SUMMARY A 66-year-old male with occluding and metastatic CRC was initially treated by positioning of a SEMS, which had to be revised 6 mo later when a symptomatic intra-stent tumor ingrowth was treated by a SEMS-in-SEMS. We hereby describe an additional episode of intestinal occlusion due to recurrence of intra-stent tumor ingrowth. This patient, despite several negative prognostic factors(splenic flexure location of the tumor, carcinomatosis with ascites, subsequent chemotherapy that included bevacizumab and two previously positioned stents(1 SEMS and 1 SEMS-in-SEMS)) underwent successful management through the placement of a tertiary SEMS-in-SEMS, with immediate clinical benefit and no procedure-related adverse events after 150 d of post-procedural follow-up. This endoscopic management has permitted 27 mo of partial control of a metastatic disease without the need for chemotherapy discontinuation and, ultimately, a good quality of life until death.CONCLUSION Tertiary SEMS-in-SEMS is technically feasible, and appears to be a safe and effective option in the case of recurrent SEMS obstruction. | Giuseppe Vanella Chiara Coluccio Emilio Di Giulio Daniela Assisi Rocco Lapenta | 2019 | World Journal of Gastrointestinal Endoscopy2019，11，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员